Статья

Epidemiological characteristics of community-acquired pneumonia during the COVID-19 epidemic in the Russian Federation

B. Zhigarlovskiy, N. Nikityuk, V. Postupailo, A. Goryaev, E. Belov, N. Nosov, A. Karmishin, A. Kruglov, I. Borisevich,
2021

COVID-19 belongs to the group of acute respiratory infections and it is often complicated with pneumonia. This study aimed to investigate manifestations of community-acquired pneumonia (CAP) epidemic process during the COVID-19 epidemic in the Russian Federation. We analyzed the official statistical data reporting the incidence of CAP in the Russian Federation in 2013–2020 and incidence of COVID-19 as registered in March–July 2020. The mean average annual CAP incidence rate that we calculated and the 2020 CAP incidence prediction allowed assessing the relationship between CAP and COVID-19. It is shown that the long-term dynamics of the incidence of CAP in the Russian Federation is characterized by a pronounced upward trend with an average annual growth rate of 6.4%. The share of adult population among the CAP cases is the largest; on average, it is 64.7% (95% CI [63.1; 66.3]). In 2020, against the background of SARS-CoV-2 circulation, the discrepancy between the actual incidence of CAP and the predicted figures reached and exceeded 558% (in July 2020). As the COVID-19 epidemic developed, the incidence of CAP was registered to increase. There was established a direct and significant correlation between the incidence of CAP and COVID-19 (rxy = 0.932; p

Цитирование

Похожие публикации

Версии

  • 1. Version of Record от 2021-02-16

Метаданные

Об авторах
  • B. Zhigarlovskiy
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • N. Nikityuk
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • V. Postupailo
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • A. Goryaev
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • E. Belov
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • N. Nosov
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • A. Karmishin
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • A. Kruglov
    Centre for Strategic Planning and Management of Biomedical Health Risks of FMBA, Moscow, Russia
  • I. Borisevich
    Federal Medical-Biological Agency, Russia, Moscow
Название журнала
  • Bulletin officiel
Выпуск
  • (1)2021
Издатель
  • Federal Medical Biological Agency
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC BY
Правовой статус документа
  • Свободная лицензия
Источник
  • dimensions